47 results about "Anti-infection drugs" patented technology

A method of administering an aerosolized anti-infective, such as a glycopeptide, to the respiratory system of a patient. A ratio of an amount of the glycopeptide, such as vancomycin, delivered to the pulmonary system of the patient in a 24 hour period to a minimum inhibitory amount for the target organ for the same period is about 2 or more. A system to introduce aerosolized medicament to a patient may include a humidifier coupled to an inspiratory limb of a ventilator circuit wye, where the humidifier supplies heated and humidified air to the patient, and an endotracheal tube having a proximal end coupled to a distal end of the ventilator circuit wye. The system may also include a nebulizer coupled to the endotracheal tube, where the nebulizer generates the aerosolized medicament.

An improved post-operative dressing for providing both breast and, notably, nipple reconstruction and which in particular establishes custom lateral supporting of the nipple annulus. A body is constructed of a medical grade silicone and exhibits a three dimensional shape adapted for placement over the reconstructed breast and an aperture defined by an inner rim configured within the body is adapted to seat therethrough an associated nipple graft in a laterally supporting and non-pressure applied fashion. A number of secondary advantages incorporated into the body include each of apertures for breathability, suction / adherence properties, and impregnation or entrainment within the body inner surface of any form of anti-infection medicine.

The invention provides an implantable prosthesis, which comprises a prosthesis body, a fixing part, a fixing part and a fixing part, wherein the prosthesis body is provided with a mounting part; the medicine carrying container is fixedly mounted on the mounting part, the medicine carrying container is provided with a containing cavity for containing medicine, and an overflowing hole and a slow release hole which are communicated with the containing cavity are formed in the medicine carrying container; wherein a medicine control cavity with variable volume is arranged in the prosthesis body, the overflowing hole is communicated with the medicine control cavity, and the slow release hole is communicated with the outside of the prosthesis body. According to the technical scheme, the problem that in the prior art, due to long-time non-healing of bones, the bone fracture plate is broken or the artificial hip joint prosthesis is loosened is effectively solved, the medicine in the containing cavity can be one of anti-infection medicine, osteogenesis promoting medicine, anti-osteoporosis medicine and anti-tumor medicine, and therefore the medicine can be used for treating osteoporosis. A doctor can select according to the actual condition of a patient, so that the implanted prosthesis can provide help for corresponding treatment.

The invention belongs to the technical field of medicine and particular relates to a novel compound of an anti-infection drug and a preparation method thereof. According to the compound, characteristic peaks are displayed at diffraction angles of 3.5 degrees, 4.6 degrees, 8.4 degrees, 12.5 degrees, 13.8 degrees, 16.2 degrees, 19.0 degrees, 19.5 degrees, 20.0 degrees, 21.1 degrees, 27.1 degrees and 33.1 degrees in an X-ray powder diffraction pattern obtained through measurement by Cu-KAlpha rays. The invention further relates to powder injection containing 100% cefazedone sodium. The new crystal from of the compound is different from that in the prior art, through experimental verification, it is surprised to find that compared with the prior art, the powder injection obtained by direct subpackage of the compound of the novel crystal form does not need any auxiliary material and is good in liquidity, the content of impurities and moisture is reduced effectively, the safety of products is good, and the stability is high.

The invention discloses furanone-quinolinone compounds which have the following structural general formula. The furanone-quinolinone compounds have good inhibiting effects on staphylococcus epidermidis, pneumonia Klebsiella, Cryptococcus neoformans and the like, and can be used for preparing anti-infection drugs for treating intestinal infection, pneumonia, wound suppuration and the like. The invention further discloses a preparation method of the furanone-quinolinone compounds.

Oxazolidinone-adenosine type compounds have the following structural general formula described in the specification; the compounds have better inhibition and killing effects on various pathogenic bacteria; a part of compounds have higher bacteriostatic activity than penicillin G, kalamycin, ketoconazole and linezolid and can be used for preparation of anti-infection drugs; the invention discloses a preparation method and a biological activity of the compounds.